الولايات المتحدة · منصات وبيانات · MarketBeat

Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approval

نشره MarketBeat · الولايات المتحدة منذ 2 س

Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

Seeking Alpha

France protests draw 400,000 as unrest threatens Macron’s final months

The Motley Fool

Here's What $10,000 Invested Equally in Nvidia, AMD, and Broadcom Could Be Worth by 2030

MarketWatch

Worried about this stock-market selloff? Relief may be coming after the midterms — no matter who wins.

Investing.com

Medpace CEO August Troendle sells $1.59 million in stock

Benzinga

Best Biotech Stocks Right Now

TheStreet